A Therapeutic Workplace to Address Poverty and Substance Use
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03519009|
Recruitment Status : Not yet recruiting
First Posted : May 8, 2018
Last Update Posted : September 3, 2018
|Condition or disease||Intervention/treatment||Phase|
|Substance Use Disorders||Behavioral: IPS Plus Abstinence-Contingent Wage Supplement||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Therapeutic Workplace to Address Poverty and Substance Use|
|Estimated Study Start Date :||September 2018|
|Estimated Primary Completion Date :||December 2022|
|Estimated Study Completion Date :||March 2023|
Experimental: IPS Plus Abstinence-Contingent Wage Supplement
Abstinence-contingent wage supplements are provided for obtaining and maintaining competitive employment.
Behavioral: IPS Plus Abstinence-Contingent Wage Supplement
Participants are offered abstinence-contingent wage supplements if they obtain and maintain competitive employment. The wage supplements are designed to promote employment while reinforcing drug abstinence. To help participants obtain and maintain competitive employment, participants will receive Individual Placement and Support (IPS) supported employment. IPS is a supported employment intervention that has been proven effective in promoting employment in adults with severe mental illness. To promote employment and prevent relapse to drug use, participants will receive IPS Plus Abstinence-Contingent Wage Supplements.
No Intervention: Usual Care Control
Counseling and referrals to employment and treatment programs.
- Alcohol Abstinence [ Time Frame: 1 year ]The number of days of alcohol abstinence during the year-long intervention
- Employment [ Time Frame: 1 year ]The number of days of employment during the year-long intervention
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03519009
|Contact: Recruitment Centeremail@example.com|
|Contact: August F. Holtyn, Ph.D.||firstname.lastname@example.org|